ArticleSleep & breathing = Schlaf & Atmung2025
Clinical phenotypes of obstructive sleep apnea in a sample of Saudi population.
Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
purposeObstructive sleep apnea (OSA) presents with diverse clinical manifestations, complicating its diagnosis and management. Cluster-based phenotyping has emerged as a promising approach to improve diagnostic precision and guide individualized therapy; however, such data are lacking in Saudi Arabia. To address this gap, we used clinical OSA clusters from a previous clustering analysis to determine their prevalence in the Saudi population.
methodsWe reviewed the records of 650 adult patients with OSA from a single sleep laboratory in Saudi Arabia. Participants were classified into sleepy, insomniac, or minimal symptomatic clusters based on their chief complaint. Demographics, anthropometrics, medical history, Epworth Sleepiness Scale (ESS), and polysomnography measurements were compared between groups.
resultsThe sleepy, insomnia, and minimally symptomatic clusters comprised 41%, 30%, and 29% of the cohort, respectively. The minimally symptomatic group was significantly younger than the sleepy and insomniac groups (47±15 vs. 50±16 vs. 52±15 years, respectively; p=0.01). The insomniac group had a lower BMI than the sleepy and minimally symptomatic groups (34±9 vs. 37±9 vs. 39±11 kg/m2, respectively; p<0.001). The sleepy group had higher ESS than the insomniac and minimally symptomatic groups (14±5 vs. 8±6 and 10±6, respectively; p<0.001). The proportion of patients with a high risk of OSA was greater in the sleepy group than in the insomniac and minimally symptomatic groups (75%, 62%, and 67%, respectively; p=0.03).
conclusionThe clinical clusters from international cohorts of sleepiness, insomnia, and minimal symptoms were applicable in patient with OSA in the Saudi population.
Indexed as
Identifiers
41205048What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.